![PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study](https://i1.rgstatic.net/publication/330639615_P621_Real-world_effectiveness_and_safety_of_vedolizumab_and_anti-TNF_in_biologic-naive_Crohn's_disease_patients_results_from_the_EVOLVE_study/links/606e1dd34585150fe98fe4a5/largepreview.png)
PDF) P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn's disease patients: results from the EVOLVE study
![PDF) 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management PDF) 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management](https://i1.rgstatic.net/publication/313399984_3rd_European_Evidence-based_Consensus_on_the_Diagnosis_and_Management_of_Crohn's_Disease_2016_Part_1_Diagnosis_and_Medical_Management/links/5fed788fa6fdccdcb81b0bd8/largepreview.png)
PDF) 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
![PDF) Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease PDF) Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease](https://i1.rgstatic.net/publication/288888762_Prevalence_and_Characteristics_of_Extra-intestinal_Manifestations_in_a_Large_Cohort_of_Greek_Patients_with_Inflammatory_Bowel_Disease/links/5699e6dd08ae748dfaff9c74/largepreview.png)
PDF) Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease
![PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/56308924/mini_magick20190112-2341-1pf0i2t.png?1547324956)
PDF) Oral azathioprine for steroid refractory severe ulcerative colitis | Gerassimos Mantzaris - Academia.edu
![Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. - Abstract - Europe PMC Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4585386/bin/AnnGastroenterol-28-417-g008.jpg)
Clinical profiles of moderate and severe Crohn's disease patients and use of anti-tumor necrosis factor agents: Greek expert consensus guidelines. - Abstract - Europe PMC
![Julien KIRCHGESNER | Professor (Associate) | MD, PhD | Hôpital Saint-Antoine (Hôpitaux Universitaires Est Parisien), Paris | Service d'Hépato-Gastro-Entérologie - Nutrition Julien KIRCHGESNER | Professor (Associate) | MD, PhD | Hôpital Saint-Antoine (Hôpitaux Universitaires Est Parisien), Paris | Service d'Hépato-Gastro-Entérologie - Nutrition](https://i1.rgstatic.net/ii/profile.image/1067677464420353-1631565552837_Q512/Julien-Kirchgesner-2.jpg)
Julien KIRCHGESNER | Professor (Associate) | MD, PhD | Hôpital Saint-Antoine (Hôpitaux Universitaires Est Parisien), Paris | Service d'Hépato-Gastro-Entérologie - Nutrition
Orally Administered Platinum Nanomarkers for Urinary Monitoring of Inflammatory Bowel Disease | ACS Nano
![Tibor HLAVATY | Senior gastroenterologist | MD, PhD, Assoc. Prof | Department of internal medicine V. | Research profile Tibor HLAVATY | Senior gastroenterologist | MD, PhD, Assoc. Prof | Department of internal medicine V. | Research profile](https://i1.rgstatic.net/ii/profile.image/277822498197506-1443249453210_Q512/Tibor-Hlavaty.jpg)